PAIP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.486200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.186000E-01
Normal-vs-Stage2
5.754000E-02
Normal-vs-Stage3
1.012400E-01
Normal-vs-Stage4
1.437770E-01
Stage1-vs-Stage2
1.958190E-02
Stage1-vs-Stage3
2.095400E-01
Stage1-vs-Stage4
2.694800E-01
Stage2-vs-Stage3
7.265000E-01
Stage2-vs-Stage4
9.549400E-01
Stage3-vs-Stage4
7.983600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.805200E-01
Normal-vs-AfricanAmerican
2.774600E-01
Normal-vs-Asian
4.250300E-02
Caucasian-vs-AfricanAmerican
9.595200E-01
Caucasian-vs-Asian
1.941610E-01
AfricanAmerican-vs-Asian
3.313000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.444000E-01
Normal-vs-Female
2.704800E-01
Male-vs-Female
4.024800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.514400E-01
Normal-vs-Age(41-60Yrs)
4.023600E-01
Normal-vs-Age(61-80Yrs)
2.106400E-01
Normal-vs-Age(81-100Yrs)
3.428400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.565400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.850190E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.479700E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.539600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.180100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.099400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.974080E-02
Normal-vs-Daily Drinker
1.667230E-01
Normal-vs-Weekly Drinker
2.273700E-02
Normal-vs-Occasional Drinker
5.961000E-01
Normal-vs-Social Drinker
4.754200E-01
Non Drinker-vs-Daily Drinker
2.624000E-01
Non Drinker-vs-Weekly Drinker
8.101000E-01
Non Drinker-vs-Occasional Drinker
1.458180E-01
Non Drinker-vs-Social Drinker
3.982000E-02
Daily Drinker-vs-Weekly Drinker
2.824600E-01
Daily Drinker-vs-Occasional Drinker
4.475000E-01
Daily Drinker-vs-Social Drinker
3.483200E-01
Weekly Drinker-vs-Occasional Drinker
1.295570E-01
Weekly Drinker-vs-Social Drinker
7.458400E-02
Occasional Drinker-vs-Social Drinker
9.959000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.292000E-01
Normal-vs-Grade 2
1.513760E-01
Normal-vs-Grade 3
6.840400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.437800E-02
Grade 1-vs-Grade 3
3.922100E-02
Grade 1-vs-Grade 4
3.292000E-01
Grade 2-vs-Grade 3
2.078200E-01
Grade 2-vs-Grade 4
1.513760E-01
Grade 3-vs-Grade 4
6.840400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.715800E-02
Normal-vs-NonDiabetic
3.136000E-01
Diabetic-vs-NonDiabetic
3.394000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.855700E-03
Normal-vs-NoPancreatitis
2.902200E-01
Pancreatitis-vs-NoPancreatitis
3.231800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.827200E-01
Normal-vs-N1
5.860000E-02
N0-vs-N1
1.419790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.960200E-03
Normal-vs-TP53-NonMutant
6.376400E-01
TP53-Mutant-vs-TP53-NonMutant
1.898470E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
